Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib
Clinical Lymphoma Myeloma and Leukemia · 2024
DOI: 10.1016/j.clml.2024.02.014 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2024. Verfasst von Fadi G Haddad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: fhaddad@mdanderson.org. Hauptthemen laut MEDLINE: Dasatinib, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Proton Pump Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: fhaddad@mdanderson.org.
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Zitieren
APA
Haddad, F. G., Nasnas, C., Sasaki, K., Paul, S., Issa, G. C., Rausch, C., Jabbour, E., & Kantarjian, H. (2024). Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2024.02.014
Vancouver
Haddad FG, Nasnas C, Sasaki K, Paul S, Issa GC, Rausch C, et al. Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib. Clinical Lymphoma Myeloma and Leukemia. 2024. doi:10.1016/j.clml.2024.02.014
BibTeX
@article{Haddad2024,
author = {Haddad, Fadi G and Nasnas, Cedric and Sasaki, Koji and Paul, Shilpa and Issa, Ghayas C and Rausch, Caitlin and Jabbour, Elias and Kantarjian, Hagop},
title = {Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2024},
doi = {10.1016/j.clml.2024.02.014}
}
EUVIMED